Ranitidine products recalled because of a nitrosamine impurity
Reason for Recall / Hazard
Product safety
Product Description & Identification
Talk to your doctor or pharmacist at your earliest convenience about alternative, non-ranitidine treatment options appropriate for your health circumstances. There are many prescription and over-the-counter drug alternatives in Canada that are authorized for the same or similar uses as ranitidine.Individuals taking a prescription ranitidine drug, including a recalled product, should not stop taking it unless they have spoken to their health care provider and obtained alternative treatment, as the risk of not treating the condition may be greater than the risk related to NDMA exposure.Contact your health care provider if you have taken a ranitidine product and you have concerns about your health.Report any health product adverse events or complaints to Health Canada.Canadians with questions about the recalls can contactApotex Inc. via Stericycle Inc. at 1-877-574-5043;Dominion Pharmacal at 1-888-550-6060, or by e-mail at med.info@pharmascience.com;Laboratoire Riva Inc. at 1-450-434-7482, or by e-mail at jlavoie@labriva.com;Pro Doc Limitée at 1-800-361-8559, or by e-mail at medinfo@prodoc.qc.ca;Ranbaxy Pharmaceuticals Canada Inc. at 1-866-840-1340, or by e-mail at canadacustomerservice@sunpharma.comSandoz Canada at 1-800-361-3062;Sanis Health Inc. at 1-866-236-4076;Sanofi Consumer Health Inc. at 1-800-636-3664 or by email at Ch.canada-ConsumerCare@sanofi.com;Sivem Pharmaceuticals ULC at 1-855-757-4836;Pharmascience Inc. at 1-888-550-6060, or by email at med.info@pharmascience.com;Teva Canada Limited at 1-800-268-4129;Vita Health Products Inc. at 1-877-637-7557.Related links:Health Canada assessing NDMA in ranitidine (2019-09-13)Apotex Inc. ranitidine recall (2019-09-24)Sanofi Consumer Health Inc. Zantac recall (2019-10-18)Pharmascience Inc. ranitidine recall (2019-10-25)Vita Health Products Inc. ranitidine recall (2019-10-25)Health Canada updates Canadians on its ongoing assessment of nitrosamine impurities in certain drugs (2019-12-02)Status of ranitidine drugs in Canada (2020-07-23)
Affected Products
Over-the-counter and prescription ranitidine drugs (LATEST UPDATE: March 11, 2022 – Pharmascience Inc. recall)
Additional Source Details
| Field | Value |
|---|---|
| N I D | 59609 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/ranitidine-products-recalled-because-nitrosamine-impurity |
| Issue | Product safety |
| Title | Ranitidine products recalled because of a nitrosamine impurity |
| Product | Over-the-counter and prescription ranitidine drugs (LATEST UPDATE: March 11, 2022 – Pharmascience Inc. recall) |
| Archived | 0 |
| Category | Health products |
| Last updated | 2022-03-11 |
| Organization | Communications and Public Affairs Branch |
| What you should do | Talk to your doctor or pharmacist at your earliest convenience about alternative, non-ranitidine treatment options appropriate for your health circumstances. There are many prescription and over-the-counter drug alternatives in Canada that are authorized for the same or similar uses as ranitidine.Individuals taking a prescription ranitidine drug, including a recalled product, should not stop taking it unless they have spoken to their health care provider and obtained alternative treatment, as the risk of not treating the condition may be greater than the risk related to NDMA exposure.Contact your health care provider if you have taken a ranitidine product and you have concerns about your health.Report any health product adverse events or complaints to Health Canada.Canadians with questions about the recalls can contactApotex Inc. via Stericycle Inc. at 1-877-574-5043;Dominion Pharmacal at 1-888-550-6060, or by e-mail at med.info@pharmascience.com;Laboratoire Riva Inc. at 1-450-434-7482, or by e-mail at jlavoie@labriva.com;Pro Doc Limitée at 1-800-361-8559, or by e-mail at medinfo@prodoc.qc.ca;Ranbaxy Pharmaceuticals Canada Inc. at 1-866-840-1340, or by e-mail at canadacustomerservice@sunpharma.comSandoz Canada at 1-800-361-3062;Sanis Health Inc. at 1-866-236-4076;Sanofi Consumer Health Inc. at 1-800-636-3664 or by email at Ch.canada-ConsumerCare@sanofi.com;Sivem Pharmaceuticals ULC at 1-855-757-4836;Pharmascience Inc. at 1-888-550-6060, or by email at med.info@pharmascience.com;Teva Canada Limited at 1-800-268-4129;Vita Health Products Inc. at 1-877-637-7557.Related links:Health Canada assessing NDMA in ranitidine (2019-09-13)Apotex Inc. ranitidine recall (2019-09-24)Sanofi Consumer Health Inc. Zantac recall (2019-10-18)Pharmascience Inc. ranitidine recall (2019-10-25)Vita Health Products Inc. ranitidine recall (2019-10-25)Health Canada updates Canadians on its ongoing assessment of nitrosamine impurities in certain drugs (2019-12-02)Status of ranitidine drugs in Canada (2020-07-23) |